Hiroshi Harada
Higashi, 8120054, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study.
Journal: BMC rheumatology
Published: August 02, 2024
Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
Journal: Clinical rheumatology
Published: March 15, 2024
Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
Journal: Clinical rheumatology
Published: July 21, 2023
Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production.
Journal: Immunological medicine
Published: January 30, 2020
Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice.
Journal: Modern rheumatology
Published: October 04, 2019
Impact of methotrexate dose on efficacy of adalimumab in Japanese patients with rheumatoid arthritis: Results from registered data analyses.
Journal: Modern rheumatology
Published: May 05, 2016
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
Journal: Modern rheumatology
Published: March 06, 2014
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
Journal: Modern rheumatology
Published: February 25, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026